StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Longeveron's price to sales ratio was 92.5× on Jan 31, 2024.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 202492.5×−140.9
2023Dec 29, 2023233.4×+58.3
2021Apr 30, 2021175.1×–

More Longeveron figures

See a number that looks wrong?